Mechanistically, MI-503 blocked the menin–MLL complex’s ability to bind to the PEG10 promoter, which is also significant for HCC cells in order to grow and migrate, leading to decreased H3K4 methylation in HepG2 and Hep3B cells [6] (Figure 2I). The gene discussed is KMT2A; the disease is hepatocellular carcinoma.